Advertisement
ICLR vs WILLF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICLR is a Hold and WILLF is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ICLR’s FA Score shows that 0 FA rating(s) are green whileWILLF’s FA Score has 0 green FA rating(s).
- ICLR’s FA Score: 0 green, 5 red.
- WILLF’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ICLR’s TA Score shows that 1 TA indicator(s) are bullish while WILLF’s TA Score has 3 bullish TA indicator(s).
- ICLR’s TA Score: 1 bullish, 4 bearish.
- WILLF’s TA Score: 3 bullish, 4 bearish.
Price Growth
ICLR (@Medical Specialties) experienced а -1.72% price change this week, while WILLF (@Medical/Nursing Services) price change was -2.92% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +1.08%. For the same industry, the average monthly price growth was +8.45%, and the average quarterly price growth was +17.97%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.09%. For the same industry, the average monthly price growth was +4.66%, and the average quarterly price growth was +25.91%.
Reported Earning Dates
ICLR is expected to report earnings on Oct 22, 2025.
Industries' Descriptions
@Medical Specialties (+1.08% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (+0.09% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ICLR | WILLF | ICLR / WILLF | |
| Capitalization | 13.6B | 8.28B | 164% |
| EBITDA | 1.37B | 4.02B | 34% |
| Gain YTD | -16.609 | 0.340 | -4,882% |
| P/E Ratio | 18.01 | 19.08 | 94% |
| Revenue | 8.09B | 22.6B | 36% |
| Total Cash | 390M | 1.14B | 34% |
| Total Debt | 3.55B | 16.2B | 22% |
ICLR | WILLF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 68 Overvalued | 67 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 83 | |
SMR RATING 1..100 | 77 | 98 | |
PRICE GROWTH RATING 1..100 | 52 | 76 | |
P/E GROWTH RATING 1..100 | 94 | 80 | |
SEASONALITY SCORE 1..100 | 75 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
WILLF's Valuation (67) in the null industry is in the same range as ICLR (68) in the Pharmaceuticals Other industry. This means that WILLF’s stock grew similarly to ICLR’s over the last 12 months.
WILLF's Profit vs Risk Rating (83) in the null industry is in the same range as ICLR (100) in the Pharmaceuticals Other industry. This means that WILLF’s stock grew similarly to ICLR’s over the last 12 months.
ICLR's SMR Rating (77) in the Pharmaceuticals Other industry is in the same range as WILLF (98) in the null industry. This means that ICLR’s stock grew similarly to WILLF’s over the last 12 months.
ICLR's Price Growth Rating (52) in the Pharmaceuticals Other industry is in the same range as WILLF (76) in the null industry. This means that ICLR’s stock grew similarly to WILLF’s over the last 12 months.
WILLF's P/E Growth Rating (80) in the null industry is in the same range as ICLR (94) in the Pharmaceuticals Other industry. This means that WILLF’s stock grew similarly to ICLR’s over the last 12 months.
| ICLR | WILLF | |
|---|---|---|
| RSI ODDS (%) | N/A | 5 days ago 23% |
| Stochastic ODDS (%) | 4 days ago 66% | 4 days ago 48% |
| Momentum ODDS (%) | 4 days ago 67% | 4 days ago 41% |
| MACD ODDS (%) | 4 days ago 66% | 4 days ago 31% |
| TrendWeek ODDS (%) | 4 days ago 66% | 4 days ago 30% |
| TrendMonth ODDS (%) | 4 days ago 67% | 4 days ago 37% |
| Advances ODDS (%) | 11 days ago 68% | 22 days ago 57% |
| Declines ODDS (%) | 4 days ago 66% | 13 days ago 43% |
| BollingerBands ODDS (%) | N/A | N/A |
| Aroon ODDS (%) | N/A | N/A |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GDO | 11.92 | 0.03 | +0.25% |
| Western Asset Global Corporate Opportunity Fund Inc | |||
| LIAE | 167.08 | N/A | N/A |
| LifeX 2050 Infl-Prt Longevity Inc ETF | |||
| ATMP | 28.50 | -0.22 | -0.75% |
| Barclays ETN+ Select MLP | |||
| FTLS | 67.84 | -0.51 | -0.75% |
| First Trust Long/Short Equity ETF | |||
| BPAY | 32.32 | -0.33 | -1.02% |
| iShares FinTech Active ETF | |||
ICLR and
Correlation & Price change
A.I.dvisor indicates that over the last year, ICLR has been loosely correlated with TMO. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ICLR jumps, then TMO could also see price increases.
| Ticker / NAME | Correlation To ICLR | 1D Price Change % | ||
|---|---|---|---|---|
| ICLR | 100% | -0.84% | ||
| TMO - ICLR | 60% Loosely correlated | +0.64% | ||
| MEDP - ICLR | 56% Loosely correlated | +0.96% | ||
| CRL - ICLR | 55% Loosely correlated | +1.04% | ||
| BRKR - ICLR | 54% Loosely correlated | +3.49% | ||
| A - ICLR | 52% Loosely correlated | +0.21% | ||
More | ||||
WILLF and
Correlation & Price change
A.I.dvisor tells us that WILLF and MEDP have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WILLF and MEDP's prices will move in lockstep.
| Ticker / NAME | Correlation To WILLF | 1D Price Change % | ||
|---|---|---|---|---|
| WILLF | 100% | N/A | ||
| MEDP - WILLF | 24% Poorly correlated | +0.96% | ||
| CLPBY - WILLF | 23% Poorly correlated | +2.59% | ||
| VERO - WILLF | 23% Poorly correlated | N/A | ||
| ICLR - WILLF | 20% Poorly correlated | -0.84% | ||
| WILYY - WILLF | 14% Poorly correlated | N/A | ||
More | ||||